​

Curanex Pharmaceuticals Ownership | Who Owns Curanex Pharmaceuticals?

OverviewFinancialsChart

Curanex Pharmaceuticals Ownership Summary

Curanex Pharmaceuticals is owned by 1.16% institutional investors, 67.82% insiders, and 31.03% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.33% of its assets in Curanex Pharmaceuticals shares.

CURX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCuranex Pharmaceuticals1.16%67.82%31.03%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20268-27.27%327,761-22.90%141.59%4-42.86%433.33%
Dec 31, 20251110.00%425,12948.60%1133.49%7-30.00%3-
Sep 30, 202510-286,093-1-10---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index92.46K0.33%92.46K
Fidelity Nasdaq Composite Index18.67K0.07%-

CURX Ownership FAQ

Who Owns Curanex Pharmaceuticals?

Curanex Pharmaceuticals shareholders are primarily institutional investors at 1.16%, followed by 67.82% insiders and 31.02% retail investors. The average institutional ownership in Curanex Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Curanex Pharmaceuticals falls below.

Does Blackrock own Curanex Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Curanex Pharmaceuticals.

Who is the top mutual fund holder of Curanex Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Curanex Pharmaceuticals shares, with 0.33% of its total shares outstanding invested in 92.46K Curanex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools